IBRX logo

ImmunityBio, Inc. (IBRX)

Profile

Full Name

ImmunityBio, Inc.

Ticker

NASDAQ: IBRX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 28, 2015

Indexes

Not included

Website

https://immunitybio.com

Employees

671

Key Details

Price

$2.26(-5.83%)

Market Cap

$2.23B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$14.74M(2270.58% YoY)

Annual EPS

-$0.62(46.02% YoY)

PE Ratio

-

Next earnings date

Nov 10, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.26
    IBRX price is $2.26

    30-Day Relative Volume

    1.01
    IBRX 30-day relative volume is 1.01

    Price Performance

    Price Most Recent Change

    -5.83%
    IBRX price was down -5.83% on Nov 3, 2025

    Price YTD Change

    -11.72%
    IBRX price is down -11.72% since January 1st

    Price 1-Year Change

    -57.2%
    IBRX price is down -57.2% year-on-year

    Price 3-Year Change

    -57.12%
    IBRX price is down -57.12% over the past 3 years

    Price Range

    Price All-Time High

    $45.42
    IBRX price is currently -95.02% below its historical high of $45.42

    Price 3-Year Low

    $1.21
    IBRX price is currently +86.78% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $2.23B
    IBRX market cap is $2.23 billion

    Market Cap 3-Year Change

    +5.52%
    IBRX market cap is up +5.52% over the past 3 years

    Market Cap All-Time High

    $14.83B
    IBRX market cap is currently -84.99% below its historical high of $14.83 billion

    Market Cap Sector Percentile

    81.55%
    IBRX market cap is higher than 81.55% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +41.35%
    IBRX shares outstanding is up +41.35% year-on-year

    Shares Outstanding 3-Year Change

    +146.05%
    IBRX shares outstanding is up +146.05% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.57
    IBRX beta is 1.57

    200-day SMA

    $2.73
    IBRX price is currently -17.29% below its 200-day simple moving average

    50-day SMA

    $2.50
    IBRX price is currently -9.43% below its 50-day simple moving average

    14-Day RSI

    39.87
    IBRX 14-day relative strength index is 39.87

    Volume

    1.01
    IBRX 30-day relative volume is 1.01

    ATR

    $0.13
    IBRX average true range is $0.13

    10-day Historical Volatility

    68.63%
    IBRX 10-day historical volatility is 68.63%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $14.74M
    IBRX annual revenue is $14.74 million

    Revenue Analysts Estimate

    $110.16M
    IBRX annual revenue is currently -86.61% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +2270.58%
    IBRX annual revenue is up +2270.58% year-on-year

    Revenue Sector Percentile

    51.13%
    IBRX annual revenue is higher than 51.13% of companies in Healthcare sector

    EPS

    EPS

    -$0.62
    IBRX annual earnings per share is -$0.62

    EPS Analysts Estimate

    -$0.44
    IBRX annual earnings per share is currently -39.61% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +46.02%
    IBRX annual earnings per share is up +46.02% year-on-year

    EPS Sector Percentile

    64.13%
    IBRX annual earnings per share is higher than 64.13% of companies in Healthcare sector

    Profit

    Gross Profit

    -$2.81M
    IBRX annual gross profit is -$2.81 million

    Gross Margin

    -19.05%
    IBRX annual gross profit margin is -19.05%

    Operating Profit

    -$344.18M
    IBRX annual operating income is -$344.18 million

    Operating Margin

    -2334.23%
    IBRX annual operating profit margin is -2334.23%

    Net Income

    -$413.64M
    IBRX annual net profit is -$413.64 million

    Net Margin

    -2805.32%
    IBRX annual net profit margin is -2805.32%

    Expenses

    Total Expenses

    $428.31M
    IBRX annual total expenses is $428.31 million

    Operating Expenses

    $341.37M
    IBRX annual total operating expenses is $341.37 million

    Cost Of Goods Sold

    $17.55M
    IBRX annual cost of goods sold is $17.55 million

    Selling, General & Administrative Expenses

    $0.00
    IBRX annual SG&A is $0.00

    Depreciation & Amortization

    $17.55M
    IBRX annual D&A is $17.55 million

    Interest Expense

    $0.00
    IBRX annual interest expense is $0.00

    Income Tax

    $0.00
    IBRX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$344.18M
    IBRX annual earnings before interest & taxes is -$344.18 million

    EBITDA

    -$326.63M
    IBRX annual EBITDA is -$326.63 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $382.93M
    IBRX annual total assets is $382.93 million

    Non Current Assets

    $198.35M
    IBRX annual long term assets is $198.35 million

    Current Assets

    $184.59M
    IBRX annual total current assets is $184.59 million

    Cash and Cash Equivalents

    $149.81M
    IBRX annual cash & cash equivalents is $149.81 million

    Accounts Receivable

    $2.36M
    IBRX annual accounts receivable is $2.36 million

    Inventory

    $8.27M
    IBRX annual inventory is $8.27 million

    Liabilities

    Total Liabilities

    $871.06M
    IBRX annual total liabilities is $871.06 million

    Long Term Liabilities

    $816.12M
    IBRX annual total long term liabilities is $816.12 million

    Current Liabilities

    $54.94M
    IBRX annual current liabilities is $54.94 million

    Accounts Payable

    $6.72M
    IBRX annual accounts payable is $6.72 million

    Debt

    Total Debt

    $789.82M
    IBRX annual total debt is $789.82 million

    Total Debt 1-Year Change

    -10.62%
    IBRX annual total debt is down -10.62% year-on-year

    Long Term Debt

    $781.10M
    IBRX annual long term debt is $781.10 million

    Short Term Debt

    $8.71M
    IBRX annual short term debt is $8.71 million

    Equity & Capital

    Shareholders Equity

    -$489.10M
    IBRX annual stockholders equity is -$489.10 million

    Book Value

    -$489.10M
    IBRX annual book value is -$489.10 million

    Retained Earnings

    -$3.38B
    IBRX annual retained earnings is -$3.38 billion

    Working Capital

    $129.64M
    IBRX annual working capital is $129.64 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$391.24M
    IBRX annual cash from operations is -$391.24 million

    Cash From Operations 1-Year Change

    -6.67%
    IBRX annual cash from operations is down -6.67% year-on-year

    Cash From Investing

    -$12.25M
    IBRX annual cash from investing is -$12.25 million

    Cash From Investing 1-Year Change

    +59.81%
    IBRX annual cash from investing is up +59.81% year-on-year

    Cash From Financing

    $281.63M
    IBRX annual cash from financing is $281.63 million

    Cash From Financing 1-Year Change

    -49.56%
    IBRX annual cash from financing is down -49.56% year-on-year

    CAPEX

    CAPEX

    $6.89M
    IBRX annual capital expenditures is $6.89 million

    CAPEX 1-Year Change

    -77.48%
    IBRX annual capital expenditures is down -77.48% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$398.12M
    IBRX annual free cash flow is -$398.12 million

    Free Cash Flow 1-Year Change

    -0.2%
    IBRX annual free cash flow is down -0.2% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -19.05%
    IBRX annual gross profit margin is -19.05%

    Operating Margin

    -2334.23%
    IBRX annual operating profit margin is -2334.23%

    Net Margin

    -2805.32%
    IBRX annual net profit margin is -2805.32%

    ROA & ROE

    ROA

    -93.23%
    IBRX annual return on assets is -93.23%

    ROE

    84.57%
    IBRX annual return on equity is 84.57%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    IBRX price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    IBRX price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    -3.90
    IBRX price to book ratio is -3.90

    PB Ratio Sector Percentile

    6.66%
    IBRX price to book ratio is higher than 6.66% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    39.33
    IBRX price to sales ratio is 39.33

    PS Ratio Sector Percentile

    84.99%
    IBRX price to sales ratio is higher than 84.99% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $2.92B
    IBRX enterprise value is $2.92 billion

    Enterprise Value Sector Percentile

    83.31%
    IBRX enterprise value is higher than 83.31% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -10.83
    IBRX EV/EBITDA is -10.83

    EV/EBITDA Sector Percentile

    13.23%
    IBRX EV/EBITDA is higher than 13.23% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    3.36
    IBRX annual current ratio is 3.36

    Quick Ratio

    3.21
    IBRX annual quick ratio is 3.21

    Leverage

    Debt To Equity

    -1.61
    IBRX annual debt to equity ratio is -1.61

    Interest Coverage Ratio

    -
    IBRX annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    5
    IBRX piotroski f-score is 5

    Altman Z-Score

    -13.33
    IBRX altman z-score is -13.33

    Analyst ratings

    Recent major analysts updates

    Sep 10, 25 HC Wainwright & Co.
    Buy
    Sep 8, 25 D. Boral Capital
    Buy
    Aug 26, 25 D. Boral Capital
    Buy
    Aug 19, 25 D. Boral Capital
    Buy
    Aug 14, 25 D. Boral Capital
    Buy
    Aug 5, 25 D. Boral Capital
    Buy
    Jul 25, 25 D. Boral Capital
    Buy
    Jul 8, 25 D. Boral Capital
    Buy
    Jun 4, 25 HC Wainwright & Co.
    Buy
    Jun 3, 25 D. Boral Capital
    Buy

    Institutional Ownership

    Screeners with IBRX included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for ImmunityBio, Inc.?
    • Does ImmunityBio, Inc. pay dividends?
    • What sector is ImmunityBio, Inc. in?
    • What industry is ImmunityBio, Inc. in?
    • What country is ImmunityBio, Inc. based in?
    • When did ImmunityBio, Inc. go public?
    • Is ImmunityBio, Inc. in the S&P 500?
    • Is ImmunityBio, Inc. in the NASDAQ 100?
    • Is ImmunityBio, Inc. in the Dow Jones?
    • When was ImmunityBio, Inc.'s last earnings report?
    • When does ImmunityBio, Inc. report earnings?

    What is the ticker symbol for ImmunityBio, Inc.?

    The ticker symbol for ImmunityBio, Inc. is NASDAQ:IBRX

    Does ImmunityBio, Inc. pay dividends?

    No, ImmunityBio, Inc. does not pay dividends

    What sector is ImmunityBio, Inc. in?

    ImmunityBio, Inc. is in the Healthcare sector

    What industry is ImmunityBio, Inc. in?

    ImmunityBio, Inc. is in the Biotechnology industry

    What country is ImmunityBio, Inc. based in?

    ImmunityBio, Inc. is headquartered in United States

    When did ImmunityBio, Inc. go public?

    ImmunityBio, Inc.'s initial public offering (IPO) was on July 28, 2015

    Is ImmunityBio, Inc. in the S&P 500?

    No, ImmunityBio, Inc. is not included in the S&P 500 index

    Is ImmunityBio, Inc. in the NASDAQ 100?

    No, ImmunityBio, Inc. is not included in the NASDAQ 100 index

    Is ImmunityBio, Inc. in the Dow Jones?

    No, ImmunityBio, Inc. is not included in the Dow Jones index

    When was ImmunityBio, Inc.'s last earnings report?

    ImmunityBio, Inc.'s most recent earnings report was on May 8, 2025

    When does ImmunityBio, Inc. report earnings?

    The next expected earnings date for ImmunityBio, Inc. is November 10, 2025
    On this page